PLSE

Pulse Biosciences, Inc.

Healthcare
Medical - Instruments & Supplies
$3.68B market cap

Forecast run · Sep 14, 2026Upside rank 408 of 3,136

Model Signal

ForecastQ Daily Probabilities

58.2%

80.5%

59.6%

Analyst Consensus

Recommendation2.40/5 Buy

Last price$53.11

Price target$45.25

Implied move-14.8%

Analysts5

ForecastQ Portfolios

Midcap Midcap signal →

Company Profile

Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric medicine. Their primary offering is the CellFX System, a sophisticated, console-based platform that is precisely controlled via software. This system utilizes its proprietary Nano-Pulse Stimulation technology to deliver extremely brief, nanosecond-duration electrical pulses. This advanced method is designed to selectively eliminate target cells without thermal damage, effectively safeguarding adjacent non-cellular tissue. The CellFX System is applied in the treatment of various medical conditions. The company, originally incorporated in 2014 as Electroblate, Inc., officially became Pulse Biosciences, Inc. in December 2015. Its corporate headquarters are situated in Hayward, California.